Effects of a new oral contraceptive containing an antimineralocorticoid progestin, drospirenone, on the renin–aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism - Oelkers, W; Foidart, J M; Dombrovicz, N (J Clin Endocrinol Metab, 1995)